Indigenous Amazonian Origins
The preparation and use of ayahuasca — the brew combining Banisteriopsis caapi with DMT-containing plants — represents one of the most sophisticated achievements of indigenous pharmacological knowledge anywhere in the world. Identifying that these two specific plants must be combined, and that their combination produces effects qualitatively different from either component alone, required either systematic experimentation or detailed botanical knowledge passed through generations — a pharmacological discovery that Western science did not understand the mechanism of until the 1950s and 1960s.
The antiquity of ayahuasca use is not definitively established by archaeology, but chemical analysis of a shamanic bundle from Cueva del Chileno in Bolivia, dated to approximately 1000 CE, found harmine, bufotenine, dimethyltryptamine, and cocaine — suggesting organized psychedelic use incorporating MAOI-containing plants by that period, and likely earlier. Living traditions of ayahuasca use span dozens of distinct indigenous Amazonian peoples — including the Shipibo-Conibo, Shuar, Asháninka, Yawanapi, Piaroa, Tukano, Kaxinawá, and many others — each with their own ceremonies, songs, traditions, and understood relationship with the plant.
In traditional Amazonian cosmologies, Banisteriopsis caapi is typically understood not as a pharmacological tool but as a sentient being — referred to as "the vine of souls" (ayahuasca in Quechua), "the grandfather," or by dozens of regional names. The plants are understood to have agency, to teach, and to initiate. The shaman's relationship with the vine is developed over years through dietary restrictions (dietas), learning of icaros (healing songs), and accumulated ceremonial experience. The vine is typically propagated vegetatively (from cuttings), with many ceremonial gardens containing clones of plants cultivated for generations.
Early Western Documentation
Western botanical and ethnographic documentation of ayahuasca began with the expeditions of Richard Spruce through the Amazon in 1851–1853. Spruce collected specimens of Banisteriopsis caapi (then called Banisteria caapi) from the Tukanoan peoples of the Colombian Amazon and documented its preparation and ceremonial use in his posthumously published memoirs (1908). He sent botanical specimens and actual samples of the prepared vine to England, where some still exist.
Manuel Villavicencio, an Ecuadorian geographer, described drinking ayahuasca in 1858 and reported visions of "magnificent cities" — one of the earliest first-person accounts by a Western observer.
The "Telepathine" Era
Early 20th-century researchers, attempting to identify the active principle of the vine, isolated harmine and called it "telepathine" — believing it to be responsible for the reported clairvoyant and telepathic states described by indigenous users and Western investigators. In 1923, researcher Louis Lewin named the compound "banisterine" (later identified as harmine). Experiments with harmine in clinical settings in the 1920s–1930s produced some positive reports — Rafael Zerda Bayón administered harmine to patients in Colombia with claimed therapeutic results, and some researchers experimented with harmine for Parkinson's disease (with some success, as harmine inhibits monoamine oxidase, a pathway now targeted by modern Parkinson's drugs).
The Chemical Identification of DMT-MAOI Synergy
The pharmacological explanation for how oral DMT could be psychoactive — given that DMT is known to be inactive when swallowed — was not formally articulated until the work of pharmacologist Bo Holmstedt and chemist Stig Agurell in the 1960s, who established the presence of both DMT (in the admixture plants) and MAO-inhibiting beta-carbolines (in B. caapi) in ayahuasca and postulated the synergistic mechanism. The ethnobotanist Dennis McKenna (with colleagues) provided the comprehensive pharmacological study in 1984 that confirmed this mechanism definitively.
Santo Daime and Syncretic Religious Traditions
In the early 20th century, the rubber tapper Raimundo Irineu Serra (known as Mestre Irineu) founded the Santo Daime religion in Acre, Brazil, incorporating ayahuasca (called "Daime" in this tradition) as a central sacrament in a Christian-spiritualist-Afro-Brazilian syncretic framework. Later, José Gabriel da Costa founded the União do Vegetal (UDV), another ayahuasca-based religious organization. Both traditions spread from Brazil to the rest of the world, creating ongoing legal battles over religious freedom and the controlled substance status of DMT in the brew.
In 2006, the United States Supreme Court ruled unanimously in Gonzales v. O Centro Espírita Beneficente União do Vegetal that the Religious Freedom Restoration Act (RFRA) protected the UDV's sacramental use of ayahuasca. Similar cases have been decided in Brazil (where both Santo Daime and UDV are legal), the Netherlands, and other countries.
The Global Ayahuasca Renaissance
Beginning in the 1990s and accelerating through the 2000s and 2010s, interest in ayahuasca spread dramatically beyond traditional indigenous and syncretic religious communities into Western spiritual seekers, therapeutic contexts, and clinical research settings. Retreat centers in Peru, Colombia, Brazil, the Netherlands, and elsewhere began serving international visitors seeking healing, spiritual development, and psychological insight. Clinical research — particularly from groups in Barcelona (Jordi Riba and colleagues), Zurich, and North America — established robust evidence for ayahuasca's potential therapeutic effects on depression, PTSD, addiction, and existential distress. The Global Ayahuasca Survey has documented tens of thousands of international participants, providing substantial epidemiological data on benefits, risks, and contextual factors.
